Menu

A registered not
for profit charity

Our Work

Menstrual Hygiene Management

Menstrual Hygiene Management

Countries: Ethiopia - India - Kenya

Understand the menstrual journey of Adolecent Girls and Young Women (AGYW), the role of their ecosytem of influencers (parents, siblings (sisters), teachers and Community Health Workers (CHWs)), what AGYW use, the barriers and what they need

View Work

Research Concept Creation

Research Concept Creation

Countries: Sub-Saharan Africa (SSA)

Exploring and ideating research concepts and uncovering research gaps in the Multipurpose Prevention Technologies (MPT) / HIV / Family Planning (FP) prevention arena

View Work

The Contraceptive Vaginal Ring
(CVR)

The Contraceptive Vaginal Ring (CVR)

Countries: Kenya - Nigeria

Understand the appeal of Annovera - Contraceptive Vaginal Ring (CVR), develop and test visual concepts for the CVR as well as Consumer Target Product Profiles (CTPPs) and forecast its potential market impact. Refine CTPPs and visual concepts post qualitative and quantitative phases

View Work

MPTs - Strategy, Research & Product Development

MPTs - Strategy, Research & Product Development

Countries: EU, SSA + USA

Understand the current landscape for research and product development in Multipurpose Prevention Technologies (MPT), HIV and Family Planning (FP) arenas; appreciate limitations / gaps and where the area could be strengthened

View Work

Strategic Framework development for Prevention and MPTs

Strategic Framework development for Prevention and MPTs

Countries: EU, SSA + USA

Support the design of a Strategic Framework Evaluation (SFE) for antiretroviral prevention (ARV) products and Multipurpose Prevention Technologies (MPTs)

View Work

HIV Prevention Products - Dapirivine Ring & Oral Truvada

HIV Prevention Products - Dapirivine Ring & Oral Truvada

Countries: South Africa

Understand the end-user appeal of HIV prevention products both generally and with focus on the Dapirivine Ring and Oral Truvada, the push and pull and eco-system of using prevention products, critical message hooks, category surroundings and likelihood to try. Refine CTPPs post qualitative and quantitative phases

View Work

HIV Prevention Products - implant, monthly pill and broadly neutralising Antibodies (bnAbs)

HIV Prevention Products - implant, monthly pill and broadly neutralising Antibodies (bnAbs)

Countries: Kenya - South Africa

Understand the lives of women and their eco-system (including community leaders/members, family, partners, friends) around health, relationships, HIV and HIV prevention. Appreciate the appeal of HIV prevention methods, value proposition, product perception, critical hooks, barriers, and likelihood to try. Refine CTPPs post qualitative phase

View Work

The Contraceptive Injections (DMPA + DMPA-SC)

The Contraceptive Injections (DMPA + DMPA-SC)

Countries: Nigeria - Uganda

Understand women's and partners' contraceptive injection experience (current users, those who have stopped using, naive users). Uncover the appeal and perceived barriers of the DMPA and DMPA-sub cutaneous, Consumer Target Product Profiles (CTPPs). Appreciate the impact and perception of side-effects through human-centred design exercises. Understand willingness to try and impact of attribute comparisons across the discussion through Routes2Results' (R2R) trademarked behavioural economics-based exercise 'Quickfires'. Refine CTPPs post qualitative and quantitative phases. Quantitatively test various profiles, appeal, and forecast likelihood of trial/use and impact on contraceptive market

View Work

The Contraceptive Intrauterine System (IUS)

The Contraceptive Intrauterine System (IUS)

Countries: Kenya - Nigeria

Understand appeal of the IUS with end-users and healthcare providers (HCPs) - looking at Consumer Target Product Profiles (CTPP). Understand the value proposition of the IUS, likelihood to try and why, as well as appreciating the most impfactful messaging set. Refine CTPP post both qualitative and quantitative phases

View Work

Mental Health - 2nd Generation Anti-Psychotics

Mental Health - 2nd Generation Anti-Psychotics

Countries: Rwanda

Understand the patient journey from the perception of critical healthcare providers (HCPs), check for consistencies and differences between HCPs and patients. Understand the current treatment pathway, its benefits, and opportunities to strengthen skills. Test / check 2nd generation TPP for appeal, resonance, importance and likely impact. Support the creation of an HCP-focused support program

View Work

Vaccine Linkage Strategy and Implementation

Vaccine Linkage Strategy and Implementation

Countries: Nepal

A review of the MR-SIA campaign in Nepal from all stakeholders, from on-the-ground implementers at health facility and community levels (vaccinators and FCHVs) to federal functionaries involved in the strategic planning, facilitating, and monitoring of the campaign. Understand how, and how well, the program ran, how it reached the under-immunised populations, what could have been improved, needs created from the program, and needs met by the program

View Work

Contraceptive in Development: Lyndra's Monthly Oral Contraceptive

Contraceptive in Development: Lyndra's Monthly Oral Contraceptive

Countries: Bangladesh - Senegal - Zimbabwe

Provide feedback on Lyndra product-based attributes and determine the critical attributes that affect user experience, and utilize this to inform early technical design. Understand profile impact, refine messaging post qualitative and quantitative phases, and check appeal

View Work

Contraceptive in Development: Micro Array Patches (MAPs)

Contraceptive in Development: Micro Array Patches (MAPs)

Countries: Ghana - Kenya - Uganda

Gain an understanding of the Micro Array Patch (MAP) product appeal by its product characteristics, design/look and value proposition. A deeper understanding of potential biases, barriers, or unforeseen design issues with the product. Specific, actionable product design iteration and development recommendations. Quick-fire attribute survey findings based on attributes of the various MAPs. Quantitative Max Diff exercise and motivation to use analysis, and the relative appeal of each attribute

View Work